AGNCM vs CUBE

AGNCM's deterministic health scores signal significant financial distress: a Piotroski F-Score of 3/9 indicates weak operational and financial health, while the absence of an Altman Z-Score raises red flags for potential bankruptcy risk. Despite impressive revenue and earnings growth (546% and 772% YoY), these are likely driven by one-time or non-recurring factors given the implausibly high margins (92.93% profit margin, 100% gross margin) and extreme leverage (Debt/Equity of 6.89). The stock trades at a premium valuation (Price/Book of 2.64) with no intrinsic value or Graham Number available, suggesting overvaluation. Dividend yield is high (8.82%) but unsupported by sustainable earnings, making it a potential yield trap.

CUBE exhibits significant valuation misalignment and deteriorating financial fundamentals. The deterministic baseline is weak, with a Piotroski F-Score of 4/9 (Stable/Weak) and a current price of $39.54 that vastly exceeds both the Graham Number ($19.83) and the Intrinsic Value ($10.22). Most concerning is the unsustainable dividend payout ratio of 143.15% coupled with a -21.70% YoY decline in earnings growth. With zero earnings beats in the last four quarters and bearish insider activity, the stock appears heavily overvalued.